Fennec Pharmaceuticals Inc (TSX:FRX)
C$ 7.07 0 (0%) Market Cap: 193.47 Mil Enterprise Value: 178.15 Mil PE Ratio: 135.96 PB Ratio: 0 GF Score: 32/100

Fennec Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 12, 2023 / 02:00PM GMT
Release Date Price: C$11.65 (+2.28%)
Khalid Islam
Fennec Pharmaceuticals Inc. - Chairman, Board of Directors

Good morning, ladies and gentlemen, and welcome to this Annual Meeting of the Shareholders of Fennec Pharmaceuticals. I'm Khalid Islam, the Chairman of the Board of the company. I'll be the Chairman of this meeting, which I now call to order.

We will begin with a formal legal business of the meeting. After the formal business has been concluded, Rosty Raykov, our CEO will provide a presentation of the company's business progress. As Chairman, I appoint Randy Taylor to act as Secretary and Scrutineer.

The notice calling this meeting together with the related management information circular dated April 24, 2023, and form of proxy were mailed to shareholders as required by statute. I received a statutory declaration from Broadridge attesting to the mailing, and I direct the Secretary to attach a declaration to the minutes of this meeting.

Additional copies of the notice and the circular are also available at this meeting. Accordingly, I dispense with the reading of the notice. The Secretary has placed before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot